Following a meeting with the US FDA, clinical-stage biotech Dimerix has confirmed the appropriate primary endpoint for full ...

Morgan Rich, a living recipient, and her father, Lowell Ghosley, her kidney donor, highlight their advocacy for organ ...

The firm highlighted the potential for the company’s drug, Filspari, to address the significant unmet medical need in focal segmental glomerulosclerosis (FSGS). According to InvestingPro data ...

After being rushed to the emergency room with severe stomach pain, McConnell-Brent learned the problem was her kidneys and ...

Doctors discovered that one of her kidneys was leaking too much protein during a routine check-up and decided to do ...

After being rushed to the emergency room with severe stomach pain, McConnell-Brent learned the problem was her kidneys and ...

ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 for treatment of chronic kidney diseases, initially focusing on FSGS as the lead. Plans for indication expansion include treatments ...

Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $30 from $32 and keeps an Outperform rating ...

Without telling her daughter, Nija got tested to see if she could donate one of her kidneys. Doctors told her the chance of ...

A mother and daughter are graduating from nursing school together after going through a medical journey of their own.